MIRA INFORM REPORT

 

 

Report Date :

31.07.2007

 

IDENTIFICATION DETAILS

 

Name :

VINH PHUC PHARMACEUTICAL JOINT STOCK COMPANY

 

 

Registered Office :

10 To Hieu Str, Vinh Yen Town, Vinh Phuc Province

 

 

Country :

Vietnam

 

 

Date of Incorporation :

1996

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Producing and trading in pharmaceutical products, chemicals, and cosmetics

Trading medical materials and equipment

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 


 

SUBJECT IDENTIFICATION & LEGAL FORM

 

English Name
 
VINH PHUC PHARMACEUTICAL JOINT STOCK COMPANY

Vietnamese name

 

CONG TY CO PHAN DUOC PHAM VINH PHUC

Trade name

 

VINPHACO

Former name

 

VINHPHUC PHARMACEUTICAL MEDICAL SUPPLY COMPANY

Current legal status

 

Joint Stock Company

Former legal status

 

State Owned Company

Founded

 

1996

Equitization

 

June 23rd 2004

Business Registration No.

 

1903000089

Date of issuance

 

June 23rd 2004

Place of issuance

 

Vinh Phuc of Planning and Investment Department

Registered capital total

 

17,832,000,000.00 VND

Tax code

 

2500154594

Total Employees

 

350 employees

Qualification

 

Qualified

 

 

ADDRESSES

 

Head Office

Address

 

10 To Hieu Str, Vinh Yen Town, Vinh Phuc Province

Country

 

Vietnam

Tel

 

(84-211) 861233

Fax

 

(84-211) 862774

 

Branch in Hanoi City:

Address

 

No. 9, Lane.55, Huynh Thuc Khang Str., Hanoi City

Country

 

Vietnam

Tel

 

(84-4) 7733959

Fax

 

(84-4) 7733932

 

 

DIRECTORS

 

2. NAME

 

DO VAN DOANH

Position

 

Director

Date of birth

 

November 10th 1957

ID No.

 

135180034

Issued on

 

September 10th 2002

Issued by

 

Vinh Phuc Police Station

Nationality

 

Vietnamese

 

1. NAME

 

Mr, DO NGOC SON

Position

 

Chief of Branch in Hanoi city

Nationality

 

Vietnamese

 

BUSNESS ACTIVITIES

 

Following are the main business activities of the Subject:

·         Producing and trading in pharmaceutical products, chemicals, and cosmetics

·         Trading medical materials and equipment

·         Import – export pharmaceutical products and medical materials

 

 

IMPORT & EXPORT ACTIVITIES

 

IMPORT: The Subject imports from South Korea, India, France and Germany, China

EXPORT: The Subject exports to Laos.

 

 

BANKERS

 

1. BANK FOR INVESTMENT AND DEVELOPMENT OF VIET NAM  – Branch in Vinh Phuc

Address

 

No. 8 Kim Ngoc Str, Vinh Phuc Town, Vinh Phuc Province

Tel

 

(84-211) 862761

Fax No

 

(84-211) 862510

Acc No

 

42510000000088

Note: The given address of banker is not correct.

 

2. BANK FOR FOREIGN TRADE OF VIET NAM

Address

 

No. 198 Tran Quang Khai Str, Hoan Kiem Dist, Hanoi City

Tel

 

(84-4) 9343137

Fax No

 

(84-4) 8269067

Telex

 

411504/411229 VCB - VT

Swift

 

BFTV VNVX

 

 

SHAREHOLDERS

 

1. NAME

 

Mr. DO VAN DOANH

Position

 

Director

Date of birth

 

November 10th 1957

ID No.

 

135180034

Issued on

 

September 10th 2002

Issued by

 

Vinh Phuc Police

Nationality

 

Vietnamese

Share

 

9,170 shares

 

2. NAME

 

Mr. TRAN NGOC SENH

Position

 

Deputy director

Current address

 

No. 153 Trung Liet Str., Dong Da Dist., Hanoi City

Tel home

 

(84-4) 8573625

Mobil

 

+84 0913205430

Share

 

3,560 shares

 

3. NAME

 

Mrs. VU THI BINH

Position

 

Shareholder

Current address

 

Vinh Phuc Province

National

 

Vietnamese

Share

 

3,528 shares

 

4. NAME

 

Mrs. NGUYEN THI HUAN

Position

 

Shareholder

Current address

 

Vinh Phuc Province

National

 

Vietnamese

Share

 

3,650 shares

 

5. NAME

 

Mrs. TRAN THI THUY

Position

 

Shareholder

Current address

 

Vinh Phuc Province

National

 

Vietnamese

Share

 

3,540 shares

 

 

PAYMENT HISTORY AND EXPERIENCES

 

Trade Morality

 

Fairly

Liquidity

 

Normal

Former payment

 

Normal

Current Payment

 

Prompt

Former financial situation

 

Normal

Current Financial Situation

 

Developed

Litigation Data

 

No recorded

Bankruptcy

 

No recorded

 

 

FINANCIAL DATA

 

The full financial data of company is not available in latest years. Following is its financial highlight:

Unit: VND Million

Description

2005

 

Short-term Assets

    52,019

Long term Assets

    21,620

Total Assets

    73,639

Payable

    67,543

Owner’s Equity

     6,096

Total liability and owner’s equity

    73,639

 

Total Revenues

   157,750

Deduction items

     2,641

Net Revenue

   155,109

Profit from business activities

      755

Total pre-tax profit

      755

 

BALANCE SHEET

Unit: 1,000,000 VND

Description

FY 2003

FY2002

Balance Sheet Date

31/12/2003

31/12/2002

ASSETS

A. Working assets & short-term Investment

59,718

45,023

I. Cash and cash equivalents

1,588

709

II. Short-term investment

0

0

 1. Short-term securities investment

0

0

 2. Other short-term investment

0

0

 3. Provision for short-term investment

0

0

III. Receivables

49,005

36,982

1. Receivables from customers

43,584

4,796

 2. Prepayment for providers

3,163

277

 3. Value-added tax deducted

107

803

 4. Internal receivables

1,885

30,861

 5. Other receivables

266

245

 6. Provision for bad receivables

0

0

IV. Inventory

8,820

7,175

 1. Purchased goods in transit

0

0

 2. Raw materials

4,834

4,424

 3. Instrument, tools

8

7

 4. Cost for production and business in process

883

413

 5. End products

1,495

1,433

 6. Goods

871

898

 7. Goods on consignment

729

0

 8. Provision for devaluation of stocks

0

0

V. Other current assets

305

157

 1. Advances

123

130

 2. Prepaid expenses

182

27

 3. Pending expenses for transfer

0

0

 4. Pending assets

0

0

 5. Mortgage, collateral and short run collateral

0

0

VI. Administrative

0

0

 1. Administrative expenses for previous year

0

0

 2. Administrative expenses for current year

0

0

B. Fixed assets & Long term investment

13,169

4,497

I.  Fixed assets

2,951

3,717

1. Tangible fixed assets

2,951

3,717

   + Original cost

11,553

10,063

   + Accumulated depreciation value

-8,602

-6,346

2.  Financial leasing fixed assets

0

0

   + Original cost

0

0

   + Accumulated depreciation value

0

0

3. Intangible fixed assets

0

0

   + Original cost

0

0

   + Accumulated depreciation value

0

0

II. Long term investment

0

0

1. Long-term securities investment

0

0

2. Joint-venture capital contribution

0

0

3. Other long-term investment

0

0

4. Provision for long-term investment devaluation

0

0

III. Capital construction in process

10,218

780

IV. Other

0

0

TOTAL ASSETS

72,887

49,520

LIABILITIES

A. Payable loans

67,435

44,221

I. Short term payables

56,361

41,251

1. Short-term borrowings

30,508

20,694

2. Due long-term liabilities

0

0

3. Payables to supplier

25,347

17,582

4. Prepayment of buyer

68

48

5. Taxes and accounts dutiable

-316

1,281

6. Employee payments

564

657

7. Internal payables

0

924

8. Other payables

190

65

II. Long term loans

11,074

2,970

1. Long-term borrowings

8,614

446

2. Long-term payables

2,460

2,524

III. Other payables

0

0

1. Payable expenses

0

0

2. Pending assets

0

0

3. Receipts long-term collateral and deposit

0

0

B. Owner’s Equity:

5,452

5,299

I. Capital and Funds

5,295

5,209

1. Working capital

5,100

5,100

2. Differences from asset revaluation

0

0

3. Exchange rate differences

0

0

4. Development investment funds

195

109

5. Reserved funds

0

0

6. Retained profit

0

0

7. Construction capital sources

0

0

II. Other administrative and fund sources

157

90

1. Provident funds for unemployment

0

0

2. Reward and welfare funds

157

90

3. Management funds of higher level

0

0

4. Functional operation funds

0

0

5. Fund sources formed by fixed assets

0

0

TOTAL LIABILITY AND EQUITY:

72,887

49,520

 

PROFIT & LOSE ACCOUNT

Description

FY 2003

Total revenue

164,861

Deductions Items

10,776

- Discount

0

- Devaluation

9

- Return of sold goods

10,767

- Turnover tax, Luxury tax & Export tax

0

1. Net revenue

154,085

2. Cost of goods sold

141,944

3. Gross Profit

12,141

4. Sales expenses

6,303

5. Enterprise administrative expenses

4,622

6. Net income from business activities

1,216

Income from financial activities

2,418

Expenditure from financial activities

3,327

7. Net income from financial operation

-909

Irregular income

326

Irregular expenditure

380

8. Irregular Profit

-54

9. Total pre-tax profit

253

10. Income tax

81

11. After tax profit

172

 

 

FINANCIAL FACTORS

 

Description

FY2003

FY2002

Current Liquidity Ratio

1.06

1.09

Quick Liquidity Ratio

0.90

0.92

Inventory Circle

17.75

0.00

Average Receive Period

116.08

#DIV/0!

Utilizing Asset Performance

2.11

0.00

Liability / Total Asset (%)

92.52

89.30

Liability / Owner's Equity (%)

1,236.89

834.52

Income Before Tax / Total Asset (%) ROA

0.35

0.00

Income Before Tax / Owner's Equity (%) ROE

4.64

0.00

Income Before Tax / Total Revenue (%) NPM

0.15

#DIV/0!

Gross Profit / Total Revenue (%) GPM

7.36

#DIV/0!

 

 

INTERPRETATION

 

The Vinh Phuc Pharmaceutical Joint Stock Company, its forerunner was state owned company, was established in 1959, with name as Vinh Phuc Pharmaceutical Medical Supply Company. Head office is located at Vinh Yen Town, Vinh Phuc Province. In 2004, VINPHACO was changed to Joint Stock Company. At present, it has 350 employees working and increased legal capital to 17,832 million VND. All the shareholders of the subject are its staffs and board of management, the state holds zero percent. 

 

The subject is specializing in manufacturing, trading, import – export of pharmaceutical products, medical materials, health equipment… The subject imports pharmaceutical products from Korea, India, France.. and medical materials from China.

 

In the beginning of 2007 Vinphanco has become the sole producer and distributor of an anti-cancer injection, Aslem in Vietnam. The drug, a success of a national – level research project conducted by Hanoi Pharmaceutical University, is able to boost immunity and inhibit the development of cancerous cells. Aslem was tested clinically on over 100 patients at the Hanoi-based Vietnam-Germany Hospital and showed good results.

In general, its operation is fairly stable. It seems stable for development. Its market share and position in the industry is normal. The subject has capacity to meet its financial commitments. No caution needed for small and normal transactions.

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions